Journal: Molecular Medicine Reports
Article Title: MG132 induces cell type‑specific anticancer effects in uterine leiomyosarcoma cell lines
doi: 10.3892/mmr.2025.13524
Figure Lengend Snippet: MG132 modulates autophagy in Ut-LMS cells. (A) Flow cytometry analysis of LC3 protein levels in MG132-treated SK-LMS-1, SK-UT-1B and SK-UT-1 cells. Cells were treated with MG132 (0.5 and 1 µM) for 24 h, followed by staining with an anti-LC3 antibody. The flow cytometry analysis quantified the number of LC3-positive cells, which reflected autophagy induction. (B) Western blot analysis of LC3 expression in MG132-treated Ut-LMS cell lines. Elevated LC3 II levels in cells indicate the conversion from LC3 I to LC3 II, a hallmark of autophagy induction. Cells were treated with MG132 (0.5 and 1 µM) for 24 h, and LC3 I and LC3 II protein expression levels were measured. Band intensities are shown in the right panel, with β-actin serving as a loading control. Data are represented as means ± SD. *P<0.05 and **P<0.01. Ut-LMS, uterine leiomyosarcoma; SD, standard deviation; LC3, light chain 3.
Article Snippet: Autophagy induction by MG132 was assessed using the Muse Autophagy LC3-Antibody Based Kit (MCH200109; Luminex) and Muse Cell Analyzer following the manufacturer's instructions.
Techniques: Flow Cytometry, Staining, Western Blot, Expressing, Control, Standard Deviation